Filing Details

Accession Number:
0001816590-24-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-14 21:12:46
Reporting Period:
2024-03-12
Accepted Time:
2024-03-14 21:12:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1816590 Compass Pathways Plc CMPS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1843859 Jay George Goldsmith Compass Pathways Plc
33 Broadwick Street
London X0 W1F 0DQ
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2024-03-12 15,740 $10.58 4,079,107 No 4 S Direct
Ordinary Shares Disposition 2024-03-12 15,740 $10.58 4,076,833 No 4 S Indirect By: Spouse
Ordinary Shares Disposition 2024-03-13 17,203 $10.80 4,061,904 No 4 S Direct
Ordinary Shares Disposition 2024-03-13 17,203 $10.80 4,059,630 No 4 S Indirect By: Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By: Spouse
No 4 S Direct
No 4 S Indirect By: Spouse
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.36 to $10.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  4. The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.
  5. Securities held by Dr. Ekaterina Malievskaia, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.65 to $11.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.